Pharmacologic Doses of Medroxyprogesterone May Cause Bone Loss Through Glucocorticoid Activity: An Hypothesis

@article{Ishida2002PharmacologicDO,
  title={Pharmacologic Doses of Medroxyprogesterone May Cause Bone Loss Through Glucocorticoid Activity: An Hypothesis},
  author={Y. Ishida and J. Heersche},
  journal={Osteoporosis International},
  year={2002},
  volume={13},
  pages={601-605}
}
Abstract: A number of studies suggest that progestagens may have beneficial effects on bone metabolism. C21 Progestin medroxyprogesterone acetate (MPA) is one of the most commonly prescribed progestins for hormone replacement therapy and in gynecologic practice. However, it appears that MPA with significant glucocorticoid (GC) activity may decrease bone density. In this review, we argue that bone loss associated with MPA administration is caused by decreased osteoblast differentiation as a… Expand
Overview on the effects of progestins on bone.
Medroxyprogesterone acetate in the management of cancer cachexia
Potency of progestogens used in hormonal therapy: Toward understanding differential actions
Sex steroids and bone: current perspectives.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 52 REFERENCES
The role of progestins in hormone replacement therapy
  • R. Lobo
  • Medicine
  • American journal of obstetrics and gynecology
  • 1992
Glucocorticoid‐Induced Osteoporosis: Both In Vivo and In Vitro Concentrations of Glucocorticoids Higher Than Physiological Levels Attenuate Osteoblast Differentiation
  • Y. Ishida, J. Heersche
  • Medicine
  • Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
  • 1998
Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes.
  • C. Westhoff
  • Medicine
  • The Journal of reproductive medicine
  • 1996
Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.
Premenopausal bone loss and depot medroxyprogesterone acetate administration
  • S. Mark
  • Medicine
  • International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
  • 1994
Adrenal steroids as parameters of the bioavailability of MA and MPA.
The effect of medroxyprogesterone acetate on the pituitary-adrenal axis.
...
1
2
3
4
5
...